SOPHIA GENETICS SA CHF0.05 Common Stock
SOPH·H82027105·US·Common Stock·Healthcare - Health Information Services-13D/G
SOPH (SOPHIA GENETICS SA CHF0.05 Common Stock) is held by 30 institutional investors as of Q1 2026. Largest holders: GENERATION INVESTMENT MANAGEMENT LLP ($33.6M), AKRE CAPITAL MANAGEMENT LLC ($18.4M), BANQUE PICTET & CIE SA ($10.9M). Net institutional sentiment: Mixed.
30
Holders
Avg rating(9 Elite)
$86.8M
Total Value
54% (36)
Fund Consensus
15 buying - 13 selling
Who's Trading
InsiderXZXu ZhenyuSell $23KJul 13, 2026
InsiderMPMenu PhilippeSell $29KJul 13, 2026
InsiderCJCamblong JurgiSell $48KJul 10, 2026
InsiderCJCamblong JurgiSell $93KJul 7, 2026
InsiderCJCamblong JurgiSell $118KJul 6, 2026
InsiderMRMuken RossSell $51KJul 6, 2026
InsiderXZXu ZhenyuSell $38KJul 6, 2026
InsiderCGCARDOZA GEORGESell $8KJul 6, 2026
ActivistBVBalderton Capital VI, S.L.P.4.9%Feb 11, 2026
13F: Insider & Congress:
Showing 1-20 of 36
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer